Search results
Found 10059 matches for
Researchers at the Kennedy Institute, part of NDORMS have repurposed the approved drug miglustat to successfully slow the progression of multiple myeloma.
Christopher Buckley
Christopher Buckley - Kennedy Professor of Translational Rheumatology and Director of Clinical Research
Abhishek Puthenveetil
Abhishek Puthenveetil - Postdoctoral Research Assistant in Immuno-Oncology
Tess Lawless
Tess Lawless - Administrative Assistant (Meetings, Events, and Communications)
Sally Pelling-Deeves
Sally Pelling-Deeves - Programme Manager - MRC CoRE in Exposome Immunology
Yoshi Itoh
Yoshi Itoh - Associate Professor and Principal Investigator Cell Migration Group